HopeStage
Back to all studies
Enrolling By InvitationNCT06572683

Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder

Device studyAges 21–75United StatesDepression
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 21 years to 75 years. Other eligibility criteria apply.

Listed locations
Los AngelesSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 12, 2024
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
84
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 21 Years to 75 Years
Official registry ID
NCT06572683
Official title
Show the full official title

Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder

Recruitment & locations

By invitation

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Who can participate?

This study is for people with depression. Listed age limits: 21 years to 75 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies